Stock listing

Frankfurt:2X1 Abivax SA Aktie

German listing (Frankfurt) of Abivax SA · home listing Euronext:ABVX

Follow Abivax SA into a list and get an email when it puts out news.

Share price · FWB:2X1

€77.00 EUR +1.15 (+1.5%)

Close on Nov 17, 2026

Past year -21.2% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€74.65 – €77.00 EURNov 17, 2026
Volume
101 sharesNov 17, 2026
Market cap
€6.72B EURAt the close on Nov 17, 2026 · price × 87.27M shares outstanding
52-week range
€61.29 – €132.76 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
€75,985 EURMedian day 24 shares · 28 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026
Abivax SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ABVX · Home€75.50 EUR-1.40 (-1.8%)128,059€75.20€76.15€74.25€76.90Close on Nov 17, 2026
NASDAQ:ABVX$82.10 USD-1.51 (-1.8%)1,372,710$82.86$84.31$81.83$83.61Close on Nov 17, 2026
LSE:0RA9€75.15 EUR-1.75 (-2.3%)2,062€76.00€76.00€74.60€76.90Close on Nov 17, 2026
OTC:AAVXF$84.80 USD0.00 (0.0%)—$84.80$84.80$84.80$84.80Close on Nov 6, 2026
Frankfurt:2X1€77.00 EUR+1.15 (+1.5%)101€74.65€77.00€74.65€75.85Close on Nov 17, 2026
Frankfurt:2X10€74.00 EUR-3.50 (-4.5%)40€74.00€74.00€74.00€77.50Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:2X1 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€75.50-0.924-1.2%€75.08€75.57€74.890
€76.42-1.941-2.5%€78.39€78.59€76.34502
€78.36+3.568+4.8%€78.65€78.74€77.932,954
€74.79-0.526-0.7%€74.79€74.79€74.790
€75.32-1.263-1.6%€77.09€77.22€75.18370
€76.58-3.505-4.4%€79.21€79.48€75.90370
€80.09+0.937+1.2%€80.27€80.28€80.00279
€79.15+2.51+3.3%€79.14€79.15€78.981,210
€76.64-0.809-1.0%€76.64€76.64€76.640
€77.45-2.985-3.7%€77.98€78.51€77.31120
€80.43-3.964-4.7%€80.43€80.43€80.433,240
€84.40+1.618+2.0%€84.40€84.40€84.4060
€82.78+1.659+2.0%€82.78€82.78€82.780
€81.12+1.881+2.4%€79.76€81.24€79.37250
€79.24-2.306-2.8%€78.56€79.25€74.390
€81.55+3.813+4.9%€81.55€81.55€81.550
€77.73+1.435+1.9%€77.73€77.73€77.730
€76.30-1.945-2.5%€76.30€76.30€76.300
€78.24-0.108-0.1%€78.25€78.77€78.17136
€78.35-0.573-0.7%€78.35€78.35€78.350
€78.92+1.349+1.7%€79.03€79.12€78.881,100
€77.57+0.039+0.1%€77.57€77.57€77.574,318
€77.54-2.586-3.2%€78.10€79.04€77.2240
€80.12-1.424-1.7%€80.26€80.28€79.89200
€81.55-1.91-2.3%€81.55€81.55€81.550
€83.46-2.068-2.4%€83.68€84.17€83.0230
€85.52-0.135-0.2%€87.29€87.70€85.260
€85.66+0.795+0.9%€85.66€85.66€85.660
€84.86+0.177+0.2%€84.86€84.86€84.860
€84.69+3.149+3.9%€81.09€85.20€80.980
€81.54-0.532-0.6%€81.57€81.57€81.48824
€82.07-3.196-3.7%€82.07€82.07€82.070
€85.27-3.499-3.9%€85.39€85.43€85.140
€88.76-1.301-1.4%€89.79€90.10€88.74225
€90.07-4.186-4.4%€93.63€93.68€89.70130
€94.25+3.228+3.5%€93.37€94.43€92.94891
€91.02-1.709-1.8%€91.02€91.02€91.020
€92.73-3.252-3.4%€92.73€92.73€92.730
€95.98-3.981-4.0%€97.00€97.65€94.5768
€99.97+0.27+0.3%€101.42€102.95€99.9110
€99.70-4.475-4.3%€99.51€99.78€99.461,929
€104.17+2.341+2.3%€104.28€104.28€103.33100
€101.83+4.449+4.6%€100.79€102.71€100.210
€97.38-0.496-0.5%€97.38€97.38€97.380
€97.88+0.469+0.5%€97.88€97.88€97.880
€97.41+1.975+2.1%€97.41€97.41€97.411,589
€95.43-1.783-1.8%€95.43€95.43€95.430
€97.22+1.652+1.7%€97.22€97.22€97.220
€95.56-1.413-1.5%€95.56€95.56€95.560
€96.98-1.181-1.2%€96.98€96.98€96.980
€98.16-3.845-3.8%€98.16€98.16€98.1627,240
€102.00+1.467+1.5%€100.18€102.46€100.01200
€100.54-1.997-1.9%€100.54€100.54€100.540
€102.53+0.398+0.4%€100.12€103.48€99.40300
€102.13+3.043+3.1%€102.13€102.13€102.1318
€99.09-3.882-3.8%€99.09€99.09€99.09400
€102.97+0.821+0.8%€102.97€102.97€102.970
€102.15-0.70-0.7%€103.05€104.25€102.09100
€102.85-0.092-0.1%€102.60€103.35€102.32400
€102.94-2.815-2.7%€102.94€102.94€102.940
Ticker
Frankfurt:2X1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Abivax (Euronext:ABVX) Q4 2023 Earnings Call

    Mon, Apr 08, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

All Abivax SA news

Financings

  • Public offering of american Depositary Shares

    Jul 6, 2026

    Closed: US$920M raised · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029

    Closed Jul 6, 2026

  • Public offering of american Depositary Shares

    Jul 2, 2026

    Made bigger: about US$920M · US$125 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen

    Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes

    Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026

  • Public offering of american Depositary Shares

    Jul 28, 2025

    Closed: US$747.5M raised · US$64 a share · Leerink Partners +5

    Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen

    Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis

    Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025

Read by 6ix AI from the company's releases

Decks

Abivax SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
Calls
1 call with a replay · 1 with a transcript · latest Apr 8, 2024
Decks
39 decks · latest July 2026

Where Abivax SA is listed

ListingExchangeCountryCurrency
Euronext:ABVX · Home listingEuronextFranceEUR
NASDAQ:ABVXNASDAQUnited StatesUSD
LS Exchange:A14UQCLS ExchangeGermanyEUR
gettex:2X1gettexGermanyEUR
LSE:0RA9LSEUnited KingdomEUR
Xetra:2X1XetraGermanyEUR
Tradegate:2X1TradegateGermanyEUR
OTC:AAVXFOTCUnited StatesUSD
Lang & Schwarz:A14UQCLang & SchwarzGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
Frankfurt:2X1 · This pageFrankfurtGermanyEUR
gettex:2X10gettexGermanyEUR
BX Swiss:ABVXBX SwissSwitzerlandCHF
Dusseldorf:2X1DusseldorfGermanyEUR
Lang & Schwarz:A3EWCPLang & SchwarzGermanyEUR
Munich:2X1MunichGermanyEUR
Hamburg:2X1HamburgGermanyEUR
Aquis:ABVXPAquisUnited KingdomEUR
BOATS:ABVXBOATSUnited StatesUSD
Frankfurt:2X10FrankfurtGermanyEUR
LS Exchange:A3EWCPLS ExchangeGermanyEUR
Stuttgart:2X1StuttgartGermanyEUR
Turquoise:ABVXPTurquoiseUnited KingdomEUR
VIE:ABVXViennaAustriaEUR
Dusseldorf:2X10DusseldorfGermanyEUR
Hamburg:2X10HamburgGermanyEUR
Munich:2X10MunichGermanyEUR
Stuttgart:2X10StuttgartGermanyEUR
Tradegate:2X10TradegateGermanyEUR
Hanover:2X1HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Abivax SA.